Molecular mechanisms of peritoneal dissemination

Japanese Journal of Gastroenterology

Volumn 97, Issue 6, 2000, Pages 680-690

  Yonemura, Yutaka ^a   Endou, Yoshio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; MATRIX METALLOPROTEINASE;

HUMAN; METASTASIS; PATHOPHYSIOLOGY; PERITONEUM TUMOR; PHYSIOLOGY; REVIEW;

CELL ADHESION MOLECULES; CYTOKINES; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS;

EID: 0346742191     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Yonemura Y, Fujimura T, Fushida S, et al: Peritonectomy as a treatment modality for patients with peritoneal dissemination from gastric cancer. Multimodality therapy for gastric cancer, (ed by Nakajima T, et al), Springer-Verlag, Tokyo, 1999; 71-80
2. Yonemura Y, Fujimura T, Fushida S, et al: A new surgical procedure (Peritonectomy) for the treatment of peritoneal dissemination. Hepato-Gastroenterol 1999; 46: 601-609
3. Yonemura Y, Fujimura T, Nishimura G, et al: Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996; 119: 437-44
4. Yonemura Y : Mechanisms of the formation of peritoneal dissemination. Peritoneal dissemination, (ed by Yonemura Y) Kanazawa : Maeda Shoten, 1998; 1-46
5. Takeichi M : The cadherin. Developments 1988; 102: 639-655
6. Meyer B, Johnson JP, Leitl F, et al : E-cadherin expression in primary and metastatic gastric cancer. Cancer Res 1993; 53: 1960-1965
7. Yonemura Y, Ninomiya I, Kaji M, et al : Decreased E-cadherin expression correaltes with poor survival in patients with gastric cancer. Anal Cell Pathol 1995; 8: 177-190
8. Shimoyaina Y, Hirohashi S, Expression of E-and P-cadherin In gastric carcinoma. Cancer Res. 1991: 51: 2185-2129
9. Hirono Y, Fushida S, Yonemura Y, et al : Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. B J Cancer 1996; 74: 2003-2007
10. Nabi IR, Watanabe H, Raz A : Identification of B 1G-F1 melanoma autocrine motility-like factor receptor. Cancer Res 1990; 50: 409-414
11. Kaji, M. Yonemura Y, Harada S, et al : Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasivencss of gastric cancer cells. Cancer Gene Ther 1996; 3: 393-404
12. Fushida S, Yonemura Y, Urano T, et al : Expression of hepatocyte growth factor (HGF) and c-met gene in human gastric cancer cell lines. Int J Oncol 1993; 3: 1067-1070
13. Ilg EC, Schafer BW, Heizmann W : Expression of S100 calcium-binding proteins In human tumors. Int J Cancer 1996; 68: 325-332
14. Takenaga K, Nakanishi H, Wada K, et al : Increased expression of S 100 A 4. a metastasis-associated gene in human colorectal adenocarcinoma. Clin Cancer Res. 1997; 3: 2309-2316
15. Yonemura Y, Endou Y, Hayashi T, et al : Role of MMP-7 on the formation of peritoneal dissemination in gastric cancer. Gastric Cancer 2000 (in press).
16. Bando E, Yonemura Y, Endou Y, et al: Immunohistochemical study of MT-MMP tissus status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis. Oncol Rep 1998; 5: 1483-1488
17. Yonemura Y, Nojima N, Kaji M, et al : E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer 1995; 76: 941-953
18. Taniguchi K, Yonemura Y, Nojima N, et al : The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocine motility factor receptor, and urokinase-type plasminogen activator receptor. Cancer 1997; 82: 2112-2121
19. Imai K, Yokohama Y, Nakanishi I, et al : Matrix metalloproteinase 7 (matrilysis) from human rectal carcinoma cells. J Biol Chem 1995; 270: 6691-6697
20. McDonnell S, Narve M, Coffey RJ, et al : Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol. Carcinogenesis 1991; 4: 521-533
21. Imai K, Ohouchi E, Aoki T, et al : Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is a complex with tissue Inhibitor of metalloproteinase-2. Cancer Res 1996; 56: 2707-2710
22. Noguchi-Takino M, Endo Y, Yonemura Y, et al : Relationship between expression of plasminogen activator system and metastatic ability in human cancers. Int J Oncology 1995; 8: 97-105
23. Bando E, Yonemura Y, Takeshita Y, et al : Intraoperative lavage for cytological examination in 1, 297 patients with gastric carcinoma. Am J Surg 1999; 178: 256-62
24. Fujimura T, Yonemura Y : Molecular diagnosis of peritoneal dissemination. Peritoneal Dissemination, (ed by Yonemura Y)., Maeda Shoten, Kanazawa, 1998; 139-146
25. Nakanishi H, Kodera Y, Torii A, et al: Detection of carcinoembryonic antigen-expressing free tumor cells In peritoneal washes from patients with gastric carcinoma by polymerase chain reaction. Ipn J Cancerr Res 1997; 88: 687-692
26. Benevolo M, Mottoless M, Cosmelli M, et al : Diagnostic and prognostic value of peritoneal Immunocyotolgy In gastric cancer. J Clin Oncol 1998; 16: 3406-3411
27. Lockett MA, Metcalf JS, Baron PL, et al : Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients. Am Surg 1999; 64: 539-43
28. Ruud P, Fodstad O, Hovig E : Identification of a novel cytokeratin 19 pseudogene that may Increase with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. In J Cancer 1999; 80: 119-125
29. Yonemura Y, Endo Y, Yamaguchi T, et al : Mechanisms of the formation of the peritoneal dissemination in gastric cancer. Int J Oncol 1996; 8: 795-802
30. Hagiwara A, Takahashi T, Sawai K, et al: Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice. Cancer Res 1994; 54: 687-692
31. Lawreance RJ, Loizidou M, Cooper AJ, et al : Importance of the omentum In the development of intra-abdominal metastases. Br J Surg 1991; 78: 117-119
32. Nakatani T, Ohotani O, Tanaka S : Lymphatic stomata in the murine diaphragmatic peritoneum. Anat Rec 1996; 244: 529-539
33. Itani K : Studies on the peritoneal absorption of particulate matter, 1959; 28: 802 824
34. Esperanca MJ, Collins D : Peritoneal dialysis efficiency in regulation to body weight. J Ped Surg 1966; 1: 162-169
35. Sugarbaker PH, Averbach AM : Kruckenberg sybdrome as a natural manifestation of tumor cell entrapment. (ed by Stigarbaker PH) Peritoneal carcinomatosis, Kluwar Academic Publisher, Boston. 1996; 163-191
36. Iitstika Y, Kaneshima S, Tanida O, et al: Intraperitoenal free cancer cells and their viability In gastric cancer. Cancer 1979; 44: 1476-1480
37. Nishimura S, Chung YS, Yashiro M, et al : CD44II plays an important role in peritoneal dissemination of scirrhous gastric cancer cells. Jpn J Cancer Res 1996; 87: 1235-1244
38. Kaufman OY, Rostovshchikov AS, Kranchev AK, et al : Response of peritoneal mesothelail cells In rats with aseptic and bacterial peritonitis. Bull Exp Biol Med 1982; 94: 100-104
39. Li X, Nagayasu H, Hamada J, et al : Enhancement of tumorigenesisand invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor. Jpn J Cancer Res 1993; 84: 1145-1149
40. Welch DR, Fabba A, Nakajima M : Transforming growth factor-stimulates mammary adenocarcinoma cell invasionand metastatic potential. Proc Natl Acad Sci USA 1990; 87: 7678-7682
41. Yashiro M, Chung YS, Nishimura S, et al : Peritonealmetastasis model for human scirrhous gastric carcinomain nude mice. Clin Exp Metastasis 1996; 14: 43-54
42. Sakamoto K, Masuda T, Mita S, et al : Interleukin-8 is constitutively and commonly produced by various human carcinoma cell lines. Int J Clin Res 1992; 22: 216-219
43. Brett J, Gerlach H, Nawroth P, et al : Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G protein. J Exp Med 1989; 169: 1977-1991
44. Murata Y : Scanning electron microscopic observations on injury of mesothelial cells caused by cancerous ascites. J Yonago Med Ass 1990; 41: 355-369
45. Gulp LA, W-C Lin, Kleinman, KL. et al : Earliest steps In primary formation and micormetastasis resolved with histochemical of gene-tagged tumor cells. J Histochem Cytochem 1998; 46: 557 567
46. Kobayashi K, Nakanishi H, Masuda, A. et al : Sequential observation of micrometastasis formation by bacterial lacZ gene-tagged Lewis lung carcinoma cells. Cancer Let 1997; 112: 191-198
47. Yonemura Y, Endou Y, Yamaguchi T, et al : Roles of VLA-2 and VLA-3 on the formation of peritoneal dissemination in gastric cancer. Int J Oncol 1996; 8: 925-931
48. Nishimura S, Chung YS, Yashiro M, et al : Role of alpha 2 beta 1-and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer 1996; 74: 1406-1412
49. Fujita S, Suzuki H, Kinoshita M, et al : Inhibition of cell attachment, Invasion and metastasis of human carcinoma cells by anti-Integrin b1 subunit antibody. Jpn J Cancer Res 1992; 83: 1317-1326
50. Yonemura Y, Nojima X, Kawamura T, et al : Correlation of peritoneal dissemination and integrin α3 expression in gastric cancer. Oncology Reports 1997; 4: 549-555
51. Aznavoorian S, Murphy AN, Stetler-Stevenson WG et al: Molecular aspects of tumor cell invasion and metastasis. Cancer 1993; 71: 1368-1383
52. Yonemura Y, Nojima N, Kaji M, et al : E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer 1995; 76: 911-953
53. Murphy G, Cockett MI, Ward RV, et al : Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. Biochem J 1991; 277: 277-279
54. Miyazaki K, Hattori Y, Umenishi F, et al : Purification of extracellular matrix-degrading metalloproteinase, matrin (PUMP-1). secreted from rectal carcinoma cell line. Cancer Res 1990; 50: 7758-7761
55. Murphy G, Cockett MI, Slephens PE, et al : Stromelysin is an activator of procollagenase. Biochem J 1987; 248: 265-268
56. Suzuki K, Enghild JJ, Morodomi T et al : Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin) Biochem 1990; 29: 7758-7764
57. Yamashita K, Azumano I, Mai M, et al : Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer 1998; 79: 187-194
58. Liotta LA, Mandler R, Murano G, et al : Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 1986; 83: 3302-3306
59. Watanabe H, Takehana K, Date M, et al : Tumor cell motility factor is the neuroleukin/phosphohexose isomerase. Cancer Res 1996; 56: 2960-2963
60. Nakamura T : Structure and function of hepatocyle growth factor. Prog Growth Factor 1991; 3: 67-85
61. Hall A : The cellular functions of small GTP-binding proteins. Science 1990; 249: 635-640
62. Yonemura Y, Mechanisms of the formation of peritoneal dissemination. Peritoneal disseminalion. (ed by Yonemura Y) Kanazawa : Maeda Shoten 1998; 447-106
63. Sugarbaker PH, Stuarl OA, Vidal-Jove J, et al : Studies of the peritoneal-plasma barrier after sytemic mitomicin C administration. Reg Cancer Treat 1993; 4: 188-194.
64. Joukov, V. Pajusolo, K., Kaipainen, A. et al : A novel vascular endothelial growth factor. VEGF-C, is a ligands for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290-298
65. Shore, VH. Wang, TH. Wang, CL. et al. Vascular endothelial growth factor and their receptors in isolated human trophoblast. Placenta 1997; 18: 657-665
66. Dvorak HF, Brown LF, Detmar M, et al : Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995; 146: 1029-1039
67. Dvorak HF : Tumors: wound that do not heal. Similarities between tumor stroma generation and wound healing. New Engl J Med 1986; 315: 1650-1659
68. Joukov V, Pajusolo K, Kaipainen A, et al : A novel vascular endothelial growth factor, VEGF-C, is a ligands for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290-298
69. Dvorak AM, Kohn S, Morgan ES, et al : The-vesiculo-vascular organelle (VV0)-a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leuk Biol 1996; 59: 100-115
70. Yonemura Y, Endo Y, Fujita H, et al : Role of VEGF-C expression on the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999; 5: 1823-1829
71. Oh SJ, Jeltsch MM, Birkenhager R, et al : VEGF and VEGF-C : Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997; 188: 96-109
72. Tabata S, Endou Y, Sasaki T, et al : Anti-tumor mechanisms of 3′ ethynyluridine and 3′ ethynylcytidine as RNA synthesis Inhibitors : development and characterization of 3′-ethynyluridine-resistant cells. Cancer Letter 1997; 116: 225-231
73. Dittmer J, Nordheim A : Ets transcription factors and human disease. Biochem Biophysic Acta 1988, 1377: F1-F12
74. Rhat NK, Fischinger P, Seth A, et al : Pleiotropic functions of ETS-1 (Riview). Int J Oncol 1996; 8: 841-846
75. Roeckl K, Yamaguchi S, Sawano A et al : Differential binding characteristics and cellular Inhibition by soluble VEGF receptors 1 and 2 Exp. Cell Re 1998; 241: 161-170